Provincia Lombardo Veneta Dell’ordine Ospedaliero Di San Giovanni Di Dio Fatebenefratelli

At Provincia Lombardo Veneta Dell’ordine Ospedaliero Di San Giovanni Di Dio Fatebenefratelli in Brescia, most studies focus on Alzheimer’s disease and related neurodegenerative diseases. The research is aimed at finding new ways to slow cognitive decline, protect brain function, and improve overall disease management.

• Testing new therapies for mild to moderate Alzheimer’s disease dementia
• Evaluating treatments intended to preserve memory and thinking skills
• Studying long-term safety and tolerability of investigational approaches
• Exploring biomarkers linked to disease progression and treatment response

This work reflects a strong clinical interest in both treatment effectiveness and early intervention for people living with or at risk for Alzheimer’s disease.

The site also investigates mental disorders linked to dementia, especially psychosis associated with Alzheimer’s disease and agitation. These trials are designed to improve behavioral symptoms that can greatly affect quality of life for patients and caregivers.

• Assessing treatments for psychosis in Alzheimer’s disease
• Studying options to reduce hallucinations and delusions
• Evaluating therapies for agitation in Alzheimer’s disease dementia
• Measuring how well symptom control can be maintained over time

This area combines psychiatric care with dementia research to address some of the most challenging symptoms seen in advanced Alzheimer’s disease.

Another important line of research at this hospital/clinic involves Dominantly Inherited Alzheimer Disease and other inherited forms of early-onset dementia. The studies aim to learn whether treatment can delay or prevent disease onset in people carrying disease-causing mutations.

• Studying prevention strategies for people at genetic risk for Alzheimer’s disease
• Tracking changes in brain-related biomarkers linked to early disease activity
• Evaluating whether investigational treatments can slow progression before symptoms worsen
• Supporting research in families affected by inherited neurodegenerative disease

This research is especially valuable for understanding how Alzheimer’s disease develops and how it might be delayed before major cognitive decline begins.

The site includes work in psychiatry beyond dementia, with a study focused on depression and the role of inflammation in treatment response. The goal is to better understand whether adding a new therapy can improve symptoms and biological markers in patients already receiving standard care.

• Investigating treatment effects in depressed patients
• Exploring links between mood symptoms and peripheral inflammatory status
• Assessing whether symptoms improve alongside biological changes
• Supporting broader research into personalized approaches for mental disorders

This adds an important non-dementia dimension to the research portfolio, connecting psychiatry with biological markers of disease.